Sinodata Co.,Ltd. (002657): Wins Bid for Chinese Center for Disease Control and Prevention Procurement Project Worth 1.986 Million Yuan

Deep News2025-10-09

According to data from Qichacha, based on the "Winning Bid Announcement for the Internet Access Service Procurement Project of the Network System Operation and Maintenance and Information Security Service Support Project of the Chinese Center for Disease Control and Prevention," Beijing Sinodata Technology Co., Ltd. announced on October 9, 2025, that it won the bid for a procurement project from the Chinese Center for Disease Control and Prevention, with a winning bid amount of 1.986 million yuan.

Related listed company: Sinodata Co.,Ltd. (002657.SZ)

Company Overview: Sinodata Co.,Ltd. (002657.SZ) recorded operating revenue of 1.167 billion yuan in 2024, with an operating revenue growth rate of 16.46%. The company's net profit attributable to the parent company was -55 million yuan, with a growth rate of 48.84% for net profit attributable to the parent company, and a return on equity of -2.99%. In the first half of 2025, the company's operating revenue was 345 million yuan, with an operating revenue growth rate of 14.36%. Net profit attributable to the parent company was -85 million yuan, with a growth rate of -71.51%.

The company currently operates in the information technology industry, with main product categories including internet services, software outsourcing services, system integration services, industry-specific software, operational platform systems, and professional consulting services. According to the 2024 annual report, the main business composition consists of: Banking imaging solutions: 54.83%; Data center comprehensive services: 25.48%; Artificial intelligence comprehensive services: 17.8%; Other businesses: 1.89%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment